CFTR and cystic fibrosis: The CF lung environment may influence how vitamin D is metabolized because of the cystic fibrosis transmembrane regulator (CFTR) mutation in bronchial cells, which decreases its ability to activate vitamin D locally, leading to impaired antibacterial activity due to chronic inflammation.